Clinical Trial Update: The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects [Phase 4]

View source ↗

Summary

The CogNaive Study, a Phase 4 trial, has completed and assessed changes in neurocognitive function in treatment-naïve HIV-1 positive subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Imperial College London | Conditions: HIV Infections | Phase 4 | Status: COMPLETED